Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Circulating Tumor Biomarkers Laboratory,
SiRIC,
Translational Research Department,
Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department
Charlotte Proudhon has not added Biography.
If you are Charlotte Proudhon and would like to personalize this page please email our Author Liaison for assistance.
[Evolution of genomic imprinting in mammals: what a zoo!].
Medecine sciences : M/S May, 2010 | Pubmed ID: 20510148
Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions.
Expert review of molecular diagnostics , 2016 | Pubmed ID: 26568208
Circulating tumor cells in breast cancer.
Molecular oncology Mar, 2016 | Pubmed ID: 26809472
Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
Molecular oncology Mar, 2016 | Pubmed ID: 26856794
International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant.
Analytical chemistry Feb, 2017 | Pubmed ID: 27935690
Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Clinical chemistry Mar, 2017 | Pubmed ID: 28073896
Circulating tumor cells: clinical validity and utility.
International journal of clinical oncology Jun, 2017 | Pubmed ID: 28238187
Quantifying HER-2 expression on circulating tumor cells by ACCEPT.
PloS one , 2017 | Pubmed ID: 29084234
Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.
Clinical chemistry Feb, 2018 | Pubmed ID: 29122835
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
Journal of the National Cancer Institute Jun, 2018 | Pubmed ID: 29659933
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy.
Nature reviews. Clinical oncology Oct, 2018 | Pubmed ID: 30050094
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2018 | Pubmed ID: 30054279
Institut Curie, PSL Research University
Charles Decraene1,2,
Amanda Bortolini Silveira1,
Marc Michel1,
François-Clément Bidard1,3,4,
Jean-Yves Pierga1,3,5,
Marc-Henri Stern1,6,
Charlotte Proudhon1
1Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department, Institut Curie, PSL Research University,
2CNRS UMR144, Institut Curie, PSL Research University,
3Department of Medical Oncology, Institut Curie, PSL Research University,
4, University Versailles Saint-Quentin-en-Yvelines,
5, University Paris Descartes,
6Inserm U830, Institut Curie, PSL Research University
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados